|
"chu ch"的相關文件
顯示項目 16-25 / 131 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases
|
Sung, PH; Fu, M; Chiang, HJ; Huang, CR; Chu, CH; Lee, MS; Yip, HK |
| 中山醫學大學 |
2021 |
Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study
|
Liao, PH; Chu, CH; Hung, YM; Tang, PL; Kuo, TJ |
| 國家衛生研究院 |
2020-08-26 |
Specimen preparation for transmission electron microscopy
|
Hsieh, YF;Chu, CH;Sharma, P;Ko, YF;Yang, CS;Tai, Lin Ai;Chen, YC;Ting, HC |
| 國家衛生研究院 |
2020-05-20 |
Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics
|
Chuang, YC;Chu, CH;Cheng, SH;Liao, LD;Chu, TS;Chen, NT;Paldino, A;Hsia, Y;Chen, CT;Lo, LW |
| 國家衛生研究院 |
2020-03-30 |
Biodegradable polymers for gene-delivery applications
|
Chen, CK;Huang, PK;Law, WC;Chu, CH;Chen, NT;Lo, LW |
| 國家衛生研究院 |
2020-02 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF;Chen, HS;Chu, CH;Chuang, LM;Ho, LT;Hsu, CC;Huang, LC; et al. |
| 中山醫學大學 |
2020 |
Soluble ST2 is a Useful Biomarker for Grading Cerebral-Cardiac Syndrome in Patients after Acute Ischemic Stroke
|
Sung, PH; Lin, HS; Chen, KH; Chiang, JY; Ko, SF; Shao, PL; Chiang, HJ; Chu, CH; Li, YC; Chai, HT; Lin, KC; Yip, HK |
| 中山醫學大學 |
2020 |
Preradiation tooth extraction and jaw osteoradionecrosis: Nationwide population-based retrospective study in Taiwan
|
Liao, PH; Chu, CH; Tang, PL; Wu, PC; Kuo, TJ |
| 中山醫學大學 |
2020 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF; Chen, HS; Chu, CH; Chuang, LM; Ho, LT; Hung, YJ; Kuo, CH; Li, HY; Lin, CH; Lin, KD; Lin, SY; Sheen, YJ; Sheu, WHH; Shin, SJ; Tsai, ST; Te Tu, S; Bai, CH; Chang, YC; Chang, TJ; Chang, CH; Chang, CJ; Chao, CC; Chen, CC; Chen, YL; Chong, K; Chuang, WL; Guo, LY; Hsieh, MC; Hsu, CC; Huang, LC; Huang, CN; Huang, YY; Hung, CS; Hung, WW; Hwu, CM; Jeng, JS; Jiang, YD; Juang, JMJ; Juang, JH; Kuo, CS; Kuo, JF; Kwok, CF; Lai, YC; Lee, MY; Lee, YJ; Lee, IT; Lee, CN; Lee, YT; Lee, TI; Lee, CH; Lin, LY; Lin, SD; Lin, KY; Lin, HJ; Lin, CH; Liu, CE; Lo, FS; Lu, CH; Lu, KC; Ma, WY; Ou, HY; Pei, D; Su, CC; Su, SL; Tan, ECH; Tien, KJ; Tsai, LK; Tseng, CH; Wang, JS; Weng, SF; Wu, WC; Yang, MC; Yang, YS; Yang, CH; Yang, WS; Yeh, JT; Yu, NC; Yu, TY |
| 中山醫學大學 |
2020 |
Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+cell therapy
|
Sung, PH; Chiang, HJ; Li, YC; Chiang, JY; Chu, CH; Shao, PL; Lee, FY; Lee , MS; Yip , HK |
顯示項目 16-25 / 131 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
